Benitec board of directors

Just when all seems lost and we find ourselves at all-time lows let’s reflect on who else believes in Benitec and ddrnai and continue to pin their reputations to our little unknown biotech hopeful.

1. Jerel Banks - love or loathe him you have to wonder why he has chosen to join the board of Benitec, bringing tens of millions of US dollars in investments from Nant Capital and recently reaffirming his interest by rising to the job of chairman. With his background and connections he must have a galaxy of other compelling opportunities to explore yet he chose us.

https://biocomglobalpartnering.org/speakers/jerel-banks/

2. Kevin Buchi - a well respected industry professional for decades recently elevated to the position of chairman of the board at Nasdaq listed Dicerna which has quadrupled in price in recent years from $3 to $13 on the back of its RNA’s pipeline including a hep b product. Like Benitec the majority of the pipeline is “undisclosed” for commercial and competition reasons and because its early research. Makes you wonder.........

https://dicerna.com/our-company/board-of-directors/

These two recent additions to the Benitec board reveal the potential and promise of ddrnai across many indications, proprietary and as an adjunct therapeutic.

And of course -

3. Patrick Soon-Shiong - the money: https://www.forbes.com/profile/patrick-soon-shiong/#49fb50091fee